Status:
COMPLETED
Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye Disease
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Dry Eye Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Efficacy study of ecabet ophthalmic solution in dry eye disease
Eligibility Criteria
Inclusion
- Diagnosed with dry eye disease
Exclusion
- Dry eye disease secondary to surgery
Key Trial Info
Start Date :
March 22 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 12 2008
Estimated Enrollment :
183 Patients enrolled
Trial Details
Trial ID
NCT00667004
Start Date
March 22 2008
End Date
September 12 2008
Last Update
September 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ISTA Pharmaceuticals, Inc.
Irvine, California, United States, 92618